These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1621002)

  • 1. Chemotherapy-induced myelosuppression.
    Maxwell MB; Maher KE
    Semin Oncol Nurs; 1992 May; 8(2):113-23. PubMed ID: 1621002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hematopoietic growth factors on chemotherapy-induced myelosuppression.
    Biesma B; Vellenga E; Willemse PH; de Vries EG
    Crit Rev Oncol Hematol; 1992 Sep; 13(2):107-34. PubMed ID: 1384547
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelosuppression and "conventional" chemotherapy: what price, what benefit?
    Canellos GP; Demetri GD
    J Clin Oncol; 1993 Jan; 11(1):1-2. PubMed ID: 8418220
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical use of hematopoietic growth factors].
    Gianni AM; Bregni M; Siena S; Tarella C; DiNicola M; Bonadonna G
    Haematologica; 1991 Jun; 76 Suppl 3():3-10. PubMed ID: 1752526
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer.
    Demetri GD
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas.
    Liem GS; Verweij J
    Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma.
    Canellos GP
    Ann Oncol; 1994; 5 Suppl 2():121-2. PubMed ID: 8204512
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology induced by hematopoietic growth factors. Introduction.
    Ryffel B
    Int Rev Exp Pathol; 1993; 34 Pt A():113-8. PubMed ID: 8454410
    [No Abstract]   [Full Text] [Related]  

  • 10. [The application of hematopoietic growth factors in oncology].
    Hoekman K; Wagstaff J; Ossenkoppele GJ; Pinedo HM
    Ned Tijdschr Geneeskd; 1991 Mar; 135(10):409-14. PubMed ID: 2020312
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic growth factors. A promising future for use in bone marrow dysfunction.
    Mazza JJ; Reding DJ; Plank GS
    Postgrad Med; 1992 Jun; 91(8):299-302, 305, 309 passim. PubMed ID: 1603758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of hematopoietic growth factors in treatment of bone marrow failure].
    Robak T; Krykowski E
    Pol Arch Med Wewn; 1994 Jul; 92(1):1-8. PubMed ID: 7971472
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotherapy in hematology: the next decade.
    Quesenberry PJ
    Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions.
    Symann M
    Curr Opin Oncol; 1991 Aug; 3(4):648-55. PubMed ID: 1932223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Hematological Toxicities Using Mathematical Modeling.
    Fornari C; O'Connor LO; Yates JWT; Cheung SYA; Jodrell DI; Mettetal JT; Collins TA
    Clin Pharmacol Ther; 2018 Oct; 104(4):644-654. PubMed ID: 29604045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The present and future of hematopoietic cytokines in clinical practice.
    George MJ
    Stem Cells; 1994; 12 Suppl 1():249-55. PubMed ID: 7696964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of hematopoietic growth factors in oncology].
    Delmer A; Zittoun R
    Bull Cancer; 1991; 78(2):115-31. PubMed ID: 2036483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of peripheral stem cell support of high-dose chemotherapy.
    Kessinger A; Armitage JO
    Important Adv Oncol; 1993; ():167-75. PubMed ID: 8099339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias.
    Sun X; Zhao YN; Qian S; Gao RL; Yin LM; Wang LP; Chong BH; Zhang SZ
    Chin J Integr Med; 2018 Mar; 24(3):200-206. PubMed ID: 28432529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic growth factors in oncology.
    Mertelsmann R; Lindemann A; Oster W; Gamm H; Kolbe K; Herrmann F
    Cancer Detect Prev; 1990; 14(6):613-6. PubMed ID: 2257558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.